BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27172772)

  • 1. Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
    Rhee EP; Clish CB; Wenger J; Roy J; Elmariah S; Pierce KA; Bullock K; Anderson AH; Gerszten RE; Feldman HI
    Am J Nephrol; 2016; 43(5):366-74. PubMed ID: 27172772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort.
    Hoefield RA; Kalra PA; Lane B; O'Donoghue DJ; Foley RN; Middleton RJ
    QJM; 2013 Oct; 106(10):915-24. PubMed ID: 23813282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.
    Goek ON; Prehn C; Sekula P; Römisch-Margl W; Döring A; Gieger C; Heier M; Koenig W; Wang-Sattler R; Illig T; Suhre K; Adamski J; Köttgen A; Meisinger C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2131-8. PubMed ID: 23739151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.
    Fan F; Jia J; Li J; Huo Y; Zhang Y
    BMC Nephrol; 2017 Jun; 18(1):190. PubMed ID: 28592280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease attenuates the plasma metabolome response to insulin.
    Roshanravan B; Zelnick LR; Djucovic D; Gu H; Alvarez JA; Ziegler TR; Gamboa JL; Utzschneider K; Kestenbaum B; Himmelfarb J; Kahn SE; Raftery D; de Boer IH
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites related to eGFR: Evaluation of candidate molecules for GFR estimation using untargeted metabolomics.
    Titan SM; Venturini G; Padilha K; Tavares G; Zatz R; Bensenor I; Lotufo PA; Rhee EP; Thadhani RI; Pereira AC
    Clin Chim Acta; 2019 Feb; 489():242-248. PubMed ID: 30153452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
    Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
    Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of renal function before and after percutaneous mitral valve repair.
    Wang A; Sangli C; Lim S; Ailawadi G; Kar S; Herrmann HC; Grayburn P; Foster E; Weissman NJ; Glower D; Feldman T
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25593120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease.
    Gosmanova EO; Zaidi S; Wan JY; Adams-Graves PE
    J Investig Med; 2014 Jun; 62(5):804-7. PubMed ID: 24781553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study.
    Roussel R; Matallah N; Bouby N; El Boustany R; Potier L; Fumeron F; Mohammedi K; Balkau B; Marre M; Bankir L; Velho G
    Am J Nephrol; 2015; 42(2):107-14. PubMed ID: 26346607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study.
    Eiselt J; Rajdl D; Racek J; Vostrý M; Rulcová K; Wirth J
    Kidney Blood Press Res; 2014; 39(1):50-7. PubMed ID: 24923294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolite concentrations and decreased GFR in the general population.
    Goek ON; Döring A; Gieger C; Heier M; Koenig W; Prehn C; Römisch-Margl W; Wang-Sattler R; Illig T; Suhre K; Sekula P; Zhai G; Adamski J; Köttgen A; Meisinger C
    Am J Kidney Dis; 2012 Aug; 60(2):197-206. PubMed ID: 22464876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
    McMahon GM; Hwang SJ; Clish CB; Tin A; Yang Q; Larson MG; Rhee EP; Li M; ; Levy D; O'Donnell CJ; Coresh J; Young JH; Gerszten RE; Fox CS
    Kidney Int; 2017 Jun; 91(6):1426-1435. PubMed ID: 28302371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematuria increases progression of advanced proteinuric kidney disease.
    Yuste C; Rubio-Navarro A; Barraca D; Aragoncillo I; Vega A; Abad S; Santos A; Macias N; Mahillo I; Gutiérrez E; Praga M; Egido J; López-Gómez JM; Moreno JA
    PLoS One; 2015; 10(5):e0128575. PubMed ID: 26016848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
    Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
    Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.